Disney’s Bob Iger Steps Down as CEO: Business Casual

Earlier this week, Disney announced that the CEO of the company, Bob Iger, was stepping down, shocking the media industry as much for its timing (his contract was through the end of 2021) as for its substance. Disney’s CEO for more than 15 years—since Michael Eisner’s departure in 2005—Iger built Disney into one of the world’s largest and most admired media and entertainment companies in the world, home to some of the most respected and beloved brands around the globe, with acquisitions that include Pixar, Marvel, Lucasfilm and 21st Century Fox. Known for his strategic vision for generating the best creative content, fostering innovation, utilizing the latest technology and expanding into new markets around the world, his sudden announcement, which came without a hint or warning, has prompted much speculation including why he stepped down, how Bob Chapek will fill his shoes, and what’s next.

On this Business Casual segment, Secure the Bag with Taylor Bagley, Daniel Litwin and Tyler Kern chat with Bagley to discuss the possible reasons for and outcomes of, as some would say, this drastic move.

“This leads us to wonder, what do we have in the future here for the company? We’ve seen changes in leadership have significant impacts on how that company moves forward, and you know, obviously this is one that isn’t going to have a small rippling effect by any means,” Bagley said.

“Disney became the giant we know it as today under Bob Iger’s leadership.” Litwin asked, “So, will a change in leadership really change the direction of the company? Was Bob Iger failing at leading the company into their digital new frontier? Or is this just kind of a PR facelift?”

Listen to the podcast to hear the discourse between Bagley, Litwin and Kern as they contemplate Iger’s possible motivation for stepping down, the success and what could be termed as failures under his leadership, and more.

For the latest news, videos, and podcasts in the Sports & Entertainment Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More